Hemostemix receives full LARTA approval
Hemostemix says it has received full approval from the LARTA Board, including ethics approval, and also provided manufacturing progress and a financing update.
Story updates
06:42:24 PM UTC
SquawkNews
Hemostemix received full LARTA ethics approval in The Bahamas for a commercial Phase 1 VesCell study and filed for price protection on a non-brokered placement of up to C$1.0M, with an initial close of C$380.5K via 7.61M units at C$0.05.Material DetailsContext by AI AnalystThis is an early-stage re…